PayerTalkCE

IMPACT
  • 0,0 (0)
  • Corsi

Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.

  1. 1 lug

    Myasthenia Gravis (MG): A Managed Care Guide for Emerging Evidence-Based Management Strategies

    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/mg-management. Managed care professionals face unique challenges in optimizing outcomes for patients with MG, a rare, chronic autoimmune neuromuscular disorder characterized by fluctuating muscle weakness and fatigue. The increasing prevalence and complexity of MG, combined with rapid advances in targeted therapies, require updated knowledge and strategic approaches to coverage, management, and equitable access.

  2. 1 lug

    Preventing Blindness: The Payer's Role in Advancing Retinal Care

    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://managedcareeye.com/preventing-blindness. This podcast will highlight challenges across the patient journey—including access to care, benefit design, and coverage decision-making—and their impact on timely diagnosis and treatment. The expert faculty will share payer perspectives on current coverage policies, care coordination, and system-level opportunities to support earlier intervention and evidence-based care. The program will also spotlight best practice strategies successfully implemented by payers to streamline policies, reduce barriers to care, and improve patient outcomes, offering actionable insights for managed care leaders seeking to optimize eye health management and prevent avoidable blindness.

    Preventing Blindness: The Payer's Role in Advancing Retinal Care

  3. 1 giu

    Bridging the Gaps: Improving Access and Timely Diagnosis for Retinal Diseases

    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/bridging-the-gaps/. This podcast will examine how payer policies shape the real world management of diabetic retinopathy (DR), diabetic macular edema (DME), and age related macular degeneration (AMD), highlighting health care provider insights on the systemic challenges that affect patient access, treatment consistency, and outcomes. Discussion will center on coverage related barriers across the patient journey, including prior authorization requirements, reimbursement constraints, and care coordination gaps that can delay or disrupt sight saving therapies. The expert faculty will outline where current prevention and treatment strategies fall short from the provider perspective and illustrate opportunities for payers to better align policies with clinical needs—ultimately strengthening care delivery, improving decision making at the point of service, and advancing system level approaches to prevent avoidable vision loss.

    Bridging the Gaps: Improving Access and Timely Diagnosis for Retinal Diseases

  4. 1 giu

    Aligning Policy with Practice: What Providers Need from Payers in Retinal Disease Management

    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/aligning-policy-with-practice/. Within the space of just a few years, several new retinal treatments have been approved promising increased durability and better patient outcomes. These conditions can significantly impact vision and quality of life for patients. This webcast will explore how clinical realities intersect with coverage policies in the management of diabetic retinopathy (DR), diabetic macular edema (DME), and age related macular degeneration (AMD). This session will highlight current practice patterns, gaps in care, and the unmet needs providers face when navigating treatment decisions for patients at risk of vision loss. Our experts will share candid perspectives on where payer policies support—or hinder—optimal outcomes, and outline practical, evidence aligned strategies payers can adopt to better enable timely, effective care. Attendees will gain a clearer understanding of the shared challenges across stakeholders and learn how collaborative best practices can improve patient outcomes in both DR/DME and AMD.

    Aligning Policy with Practice: What Providers Need from Payers in Retinal Disease Management

  5. 1 giu

    Payer/Provider Collaboration to Meet Best Practice Standards in Asthma Management

    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/asthma-management-best-practices/. Asthma remains a major public health issue in the US, with many patients still uncontrolled despite available treatments and evidence-based guidelines. This leads to preventable ER visits, hospitalizations, and significant costs—over $80 billion annually. The NCQA has updated HEDIS® for 2026 to include a new measure, Follow-Up After Acute and Urgent Care Visits for Asthma (AAF-E), which tracks if patients ages 5–64 receive an outpatient follow-up within 30 days after an asthma-related urgent or emergency visit. This educational activity is designed to increase awareness of the new HEDIS measure to improve outcomes of patients being treated for asthma for both managed care professionals and primary care providers.

    Payer/Provider Collaboration to Meet Best Practice Standards in Asthma Management

  6. 1 apr

    PayerTalkCE® Presents: Navigating the Complexities of Hypertrophic Cardiomyopathy

    This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/hypertrophic-cardiomyopathy-payertalkce/. Through a multidisciplinary discussion format, the podcast will address critical gaps in payer understanding of hypertrophic cardiomyopathy (HCM), including guideline interpretation, coverage implications, emerging pharmacologic options such as cardiac myosin inhibitors, and the importance of shared decision‑making to support individualized, high‑quality care. Using real‑world HCM case scenarios, the faculty will explore strategies to optimize benefit design, prior authorization, and access pathways to improve clinical and economic outcomes across health systems. Learners will receive targeted, practical insights that can help payers implement evidence‑based policies that enhance appropriate, timely treatment for patients with HCM.

    PayerTalkCE® Presents: Navigating the Complexities of Hypertrophic Cardiomyopathy

  7. 18/06/2025

    PayerTalkCE® Presents: Emerging HER2-targeting Therapies for the Management of GI Cancers

    In this episode of PayerTalkCE®, we will delve into the innovations around HER2-targeting therapies and their role in the treatment of select gastrointestinal cancers. Topics will include the latest evidence and the integration of new treatments into health care systems, insurance coverage, reimbursement challenges, and the overall impact on health care policy. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/gi-cancer-management/.

    PayerTalkCE® Presents: Emerging HER2-targeting Therapies for the Management of GI Cancers

  8. 18/06/2025

    PayerTalkCE® Presents: Trends in Cancer Care: Precision Oncology in Rare GI Cancers

    In this episode of PayerTalkCE® we will explore the epidemiology and burdens of gastroesophageal and biliary tract cancers. Experts will discuss the importance of early and accurate diagnosis in managing treatment efficacy and cost. The episode will also delve into the role of personalized medicine and multidisciplinary approaches and provide collaborative and actionable insights on how managed care professionals can adapt their strategies to better accommodate the complexities associated with rare GI cancers, ultimately aiming to enhance patient care while managing resource allocation effectively. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/gi-cancer-trends/.

    PayerTalkCE® Presents: Trends in Cancer Care: Precision Oncology in Rare GI Cancers
Elenco completo (43)

Descrizione

Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.

Informazioni

  • Creatore
    IMPACT
  • Anni di attività
    2022 - 2026
  • Puntate
    43
  • Classificazione
    Contenuti adatti a tutti
  • Copyright
    © Copyright 2026 PayerTalkCE
  • Sito web del podcast
    PayerTalkCE